Abstract |
Objectives: To assess the safety and communication performance of auditory brainstem implant (ABI) provision in children who were contraindicated for cochlear implantation and do not have neurofibromatosis type II (NF2).Methods: Communication performance was assessed via a battery of tests up to 24 months after first fitting. Safety was assessed intra-operatively and via post-operative adverse event reports.Results: Ten children participated in the study. The mean communication skills on all 8 tests for which inferential statistics were possible increased significantly from pre-operatively to 12 months and either again increased significantly or remained stable from 12 to 24 months. Communication development was variable: some children achieved high scores while others did not. Two serious adverse events that were device or procedure-related were reported and successfully resolved.Discussion: ABI provision in this population group was safe. Participants' auditory abilities were significantly better after 24 months of ABI use than at pre-implantation. Development was slower than that of children with a cochlear implant but may continue progressing after 24 months of use.Conclusion: ABI provision and use is safe and allows significant auditory development in children without NF2 who are contradicted for cochlear implantation.
|
Authors | Ranjith Rajeswaran, Mohan Kameswaran |
Journal | Cochlear implants international
(Cochlear Implants Int)
Vol. 21
Issue 3
Pg. 127-135
(05 2020)
ISSN: 1754-7628 [Electronic] England |
PMID | 31847793
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adolescent
- Auditory Brain Stem Implantation
- Auditory Brain Stem Implants
(psychology)
- Child
- Child Language
- Child, Preschool
- Cochlea
(abnormalities, surgery)
- Cochlear Diseases
(psychology, surgery)
- Cochlear Implantation
- Cochlear Nerve
(abnormalities, surgery)
- Communication
- Contraindications, Procedure
- Correction of Hearing Impairment
(methods, psychology)
- Female
- Humans
- Infant
- Male
- Postoperative Period
- Treatment Outcome
|